Clinical focus on a specialized colposcopy clinic for the diagnosis and treatment of cervical dysplasias.
Dr. Van Arsdale’s research follows her clinical focus on gynecologic malignancies. Her focus is translational research of HPV integration as a biomarker for progressive cervical dysplasia and cervical carcinoma.
<p>Anne Van Arsdale, MD, MSc, is an attending physician and Associate Professor, Genetics and Obstetrics & Gynecology and Women’s Health at Montefiore Einstein. She treats all gynecologic malignancies, with a focus on a specialized colposcopy clinic for the diagnosis and treatment of cervical dysplasias.</p><p>After receiving her Bachelor of Science at Georgetown University in 2001, Dr. Van Arsdale attended Columbia University, earning her Doctor of Medicine in 2005. She came to Montefiore Einstein to begin her postdoctoral training with a four-year residency in obstetrics and gynecology. After completing her residency in 2009, she attended the London School of Hygiene and Tropical Medicine in London, England, earning her Master of Science in medical statistics. Dr. Van Arsdale then returned to Montefiore Einstein to pursue a three-year fellowship in gynecologic oncology, which she completed in 2016.</p><p>Dr. Van Arsdale’s research follows her clinical focus on gynecologic malignancies. Her focus is translational research of HPV integration as a biomarker for progressive cervical dysplasia and cervical carcinoma. She is the current institutional principal investigator (PI) of the gynecologic tissue biorepository and the lead institutional PI for phase 2 and phase 3 trials for Inovio pharmaceuticals evaluating HPV therapeutic vaccination for the treatment of high grade cervical and vulvar dysplasia. Her research has been published in numerous peer-reviewed journals, abstracts and posters, and she is an ad hoc reviewer for several publications including <em>Frontiers Oncology, Gynecologic Oncology</em> and the <em>Journal of Lower Genital Tract Disease</em>.</p><p>Dr. Van Arsdale is board certified and a member of several professional organizations including the Society of Gynecologic Oncology, the American Society of Clinical Oncology and the American Association of Cancer Research. She has been the recipient of multiple internal and external award mechanisms, including the ME Strong Award from the Foundation of Women’s Cancer, a Dew Point Scholar (Department of Obstetrics & Gynecology and Women’s Health), an American Association of Obstetricians and Gynecologists Foundation (AAOGF) Scholar, the National Cancer Institute (NCI) Early Surgeon Scientist Program (ESSP) Award and an NCI K08 award.</p>